14.34
Schlusskurs vom Vortag:
$14.35
Offen:
$14.36
24-Stunden-Volumen:
504.38K
Relative Volume:
0.59
Marktkapitalisierung:
$1.21B
Einnahmen:
$2.01B
Nettoeinkommen (Verlust:
$-253.84M
KGV:
-4.6863
EPS:
-3.06
Netto-Cashflow:
$115.19M
1W Leistung:
+6.19%
1M Leistung:
+1.17%
6M Leistung:
+9.11%
1J Leistung:
+101.34%
Pediatrix Medical Group Inc Stock (MD) Company Profile
Firmenname
Pediatrix Medical Group Inc
Sektor
Branche
Telefon
(954) 384-0175
Adresse
1301 CONCORD TERRACE, SUNRISE, FL
Vergleichen Sie MD mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MD
Pediatrix Medical Group Inc
|
14.34 | 1.21B | 2.01B | -253.84M | 115.19M | -3.06 |
![]()
HCA
Hca Healthcare Inc
|
389.71 | 87.79B | 71.59B | 5.78B | 4.95B | 22.49 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
28.77 | 16.81B | 20.92B | 666.06M | 1.85B | 1.1422 |
![]()
THC
Tenet Healthcare Corp
|
177.66 | 14.54B | 20.52B | 1.46B | 1.41B | 15.12 |
![]()
EHC
Encompass Health Corp
|
120.41 | 12.02B | 5.51B | 494.70M | 386.40M | 4.84 |
![]()
UHS
Universal Health Services Inc
|
189.03 | 11.13B | 16.08B | 1.20B | 1.06B | 17.82 |
Pediatrix Medical Group Inc Stock (MD) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-16 | Eingeleitet | Macquarie | Outperform |
2024-09-26 | Hochstufung | Jefferies | Hold → Buy |
2024-06-07 | Hochstufung | Deutsche Bank | Sell → Hold |
2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
2021-06-23 | Fortgesetzt | Stifel | Hold |
2020-10-19 | Herabstufung | Deutsche Bank | Hold → Sell |
2020-01-03 | Herabstufung | Citigroup | Buy → Neutral |
2019-12-12 | Hochstufung | Stifel | Hold → Buy |
2019-09-06 | Herabstufung | BofA/Merrill | Neutral → Underperform |
2019-01-15 | Hochstufung | Citigroup | Neutral → Buy |
2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
2018-11-16 | Eingeleitet | UBS | Sell |
2018-09-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
2018-09-18 | Hochstufung | BofA/Merrill | Underperform → Neutral |
2018-08-03 | Hochstufung | Credit Suisse | Neutral → Outperform |
2018-07-12 | Eingeleitet | Leerink Partners | Mkt Perform |
2018-03-27 | Eingeleitet | Credit Suisse | Neutral |
2018-02-12 | Bestätigt | Mizuho | Neutral |
2017-12-13 | Eingeleitet | Piper Jaffray | Overweight |
2017-09-18 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
2017-05-30 | Bestätigt | Mizuho | Neutral |
2017-05-25 | Bestätigt | Stifel | Hold |
2017-05-04 | Herabstufung | BofA/Merrill | Buy → Underperform |
2017-03-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2017-03-10 | Herabstufung | JP Morgan | Overweight → Neutral |
Alle ansehen
Pediatrix Medical Group Inc Aktie (MD) Neueste Nachrichten
While Pediatrix Medical Group (NYSE:MD) shareholders have made 74% in 1 year, increasing losses might now be front of mind as stock sheds 5.0% this week - simplywall.st
Why Pediatrix Medical Group (MD) is a Top Value Stock for the Long-Term - Yahoo Finance
Rhumbline Advisers Sells 7,755 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
Zacks Research Issues Negative Forecast for MD Earnings - Defense World
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term - sharewise
Squarepoint Ops LLC Invests $132,000 in Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
Pediatrix Medical Group, Inc. (NYSE:MD) Shares Bought by California State Teachers Retirement System - Defense World
Millennium Management LLC Sells 5,573 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
Pediatrix Medical Group, Inc. (NYSE:MD) Shares Sold by Two Sigma Advisers LP - Defense World
AllianceBernstein L.P. Significantly Reduces Stake in Pediatrix Medical Group Inc. - GuruFocus
Two Sigma Investments LP Lowers Holdings in Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
Pediatrix Medical Group (MD) Down 3.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Pediatrix Medical Group, Inc. (NYSE:MD) Given Consensus Recommendation of “Hold” by Analysts - Defense World
3 Reasons to Avoid MD and 1 Stock to Buy Instead - FinancialContent
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $643,000 Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
Bank of America Corp DE Sells 144,861 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now - The Globe and Mail
Ameriprise Financial Inc. Sells 72,243 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
Pediatrix Medical Group, Inc. (NYSE:MD) Shares Purchased by Deutsche Bank AG - Defense World
Here's Why You Should Add Pediatrix Medical To Your Portfolio Now - Barchart.com
Wall Street Analysts See a 26.4% Upside in Pediatrix Medical Group (MD): Can the Stock Really Move This High? - Yahoo Finance
BNP Paribas Financial Markets Has $456,000 Position in Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
Pediatrix Medical Group Inc (MD) Stock Price Down 5.41% on May 2 - GuruFocus
Is Pediatrix Medical Group (NYSE:MD) Using Too Much Debt? - simplywall.st
Pediatrix Medical Group Reports Strong Q1 2025 Earnings Despite Revenue DeclineNews and Statistics - IndexBox
Pediatrix Medical Group shares fall as Q1 revenue declines By Investing.com - Investing.com Nigeria
The Manufacturers Life Insurance Company Sells 752 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
Comerica Bank Sells 3,075 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
Northern Trust Corp Has $12.68 Million Position in Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
Pediatrix Medical Group (MD) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance
The Return Trends At Pediatrix Medical Group (NYSE:MD) Look Promising - Yahoo Finance
Pediatrix Medical Group (NYSE:MD) Price Target Lowered to $16.00 at UBS Group - Defense World
Pediatrix Medical Group (MD) Price Target Lowered by UBS | MD St - GuruFocus
Pediatrix Medical Group (MD) Price Target Lowered by UBS | MD Stock News - GuruFocus
UBS Adjusts Price Target on Pediatrix Medical Group to $16 From $18.50, Maintains Neutral Rating - marketscreener.com
Pediatrix Medical (MD) Price Target Adjusted by UBS Analyst | MD Stock News - GuruFocus
Pediatrix Medical's Q1 Earnings Beat Estimates on Declining Costs - The Globe and Mail
Expert Outlook: Pediatrix Medical Group Through The Eyes Of 4 Analysts - Benzinga
Pediatrix Medical Group Holds Annual Shareholders’ Meeting - TipRanks
Pediatrix Medical's Q1 Earnings Beat Estimates On Declining Costs - Barchart.com
MD: Macquarie Raises Target Price for Pediatrix Medical Group | MD Stock News - GuruFocus
Pediatrix Medical Group, Inc. (NYSE:MD) Q1 2025 Earnings Call Transcript - Insider Monkey
Pediatrix Medical Group Inc (MD) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo
Pediatrix Medical Group Inc (MD) Q1 2025 Earnings Call Highlight - GuruFocus
Pediatrix Medical Group Inc (MD) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Earnings call transcript: Pediatrix Medical Q1 2025 beats forecasts, stock surges - Investing.com Nigeria
Decoding Pediatrix Medical Group Inc (MD): A Strategic SWOT Insi - GuruFocus
Pediatrix Medical Group Reports Strong Q1 Earnings - TipRanks
Pediatrix Medical Group’s Optimistic Q1 Earnings Call - TipRanks
Finanzdaten der Pediatrix Medical Group Inc-Aktie (MD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pediatrix Medical Group Inc-Aktie (MD) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
ORDAN MARK S | Director |
Nov 13 '24 |
Sale |
15.35 |
27,600 |
423,660 |
138,683 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):